2289 — Charmacy Pharmaceutical Co Balance Sheet
0.000.00%
Consumer DefensivesSpeculativeSmall CapNeutral
- HK$1.42bn
- HK$1.59bn
- CNY4.18bn
- 69
- 55
- 86
- 85
Annual balance sheet for Charmacy Pharmaceutical Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 429 | 506 | 590 | 630 | 493 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 864 | 784 | 821 | 786 | 994 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,962 | 2,019 | 2,251 | 2,238 | 2,462 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 218 | 317 | 373 | 348 | 294 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 2,354 | 2,504 | 2,799 | 2,763 | 2,866 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,786 | 1,878 | 2,162 | 2,159 | 2,256 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,877 | 2,020 | 2,297 | 2,259 | 2,271 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 477 | 484 | 503 | 504 | 594 |
Total Liabilities & Shareholders' Equity | 2,354 | 2,504 | 2,799 | 2,763 | 2,866 |
Total Common Shares Outstanding |